Nano-bio-technology | Chemistry | CMOS Semiconductors

Altratech Home2022-11-24T17:09:44+00:00

Next Generation Molecular Detection

Discover Altratech

At Altratech, our mission is to enable next generation molecular detection.

This exciting technology enables robust, straightforward and flexible molecular diagnostics in any environment.

Next Generation Molecular Detection

Discover Altratech

About Altratech

We are a team of twenty scientists engineers, including nine PhDs, has for the past seven years been researching and developing a Bioorthogonal alternative to PCR. With minimal sample preparation, the Altratech product and assay can rapidly detect and quantify molecular targets from any sample. The technology brings together nanotechnology, CMOS semiconductor technology and novel PNA chemistry to produce a unique and powerful assay. The assay named Molecular Detection by Proxy is a bead-based technology coupled with ultra-sensitive capacitance detection.

We are creating an infrastructure of technology and data to manage contagious viral diseases, important for the future of decentralised connected healthcare and wellbeing.

Based on the novel Detection by Proxy concept, Altratech has developed the next generation of molecular detection. The technology enables any person, anywhere, to rapidly and accurately measure and quantify viral RNA, DNA, antigen, or antibody samples.

Learn More

At Altratech, our mission is to enable next generation molecular detection.

This exciting technology enables robust, straightforward and flexible molecular diagnostics in any environment.

Our Product – UbiHealth

Our first product will enable at-home detection of SARS-CoV-2 RNA and multiplexed identification of Variants-of-Concern (VOC) from a self-collected saliva sample with the sensitivity and specificity of a laboratory test. The safe sealed test cartridge will eliminate the risks due to sample handling and shipping to laboratories. It addresses the post-pandemic ongoing unmet needs of a home SARS-CoV-2 viral RNA test, and real-time field surveillance.

Learn More

Any Person. Anywhere. Any Sample.

Altratech – Next Generation Molecular Detection

In the News

Altratech contracted by BARDA to deliver home-COVID test

This project has been funded in whole or in part with Federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority, under Contract No. 75A50122C00067

More Stories

Our Investors

Our Investors

Go to Top